by Patrick Delaney, LifeSite News:
INDIA, January 18, 2021 (LifeSiteNews) — While the United States continues its aggressive military roll-out of novel, expensive and dangerous pharmaceutical vaccines, India has developed a “miraculously” effective and safe COVID-19 treatment kit which costs merely $2.65 per person and has helped put the nation’s case and fatality rates in “steep decline.”
Last month, several medical experts testified before the U.S. Senate Homeland Security Committee in favor of authorizing ivermectin for early treatment of the novel coronavirus. Among them, Dr. Pierre Kory, founding member of Front Line Covid-19 Critical Care Alliance (FLCCC), explained that ivermectin, a Nobel Prize–winning anti-parasitic agent, “basically obliterates transmission of this virus,” with “miraculous effectiveness.”
TRUTH LIVES on at https://sgtreport.tv/
“I’ve been treating COVID pretty much every single day since the onset,” Kory said. “When I say ‘miracle’ I do not use that term lightly…that is a scientific recommendation based on mountains of data that has emerged in the last three months.”
FLCCC has developed a treatment regimen incorporating ivermectin, which the group claims has led to up to 83% lower-than-average COVID-19 death rates in hospitals that have applied it.
However, the Food and Drug Administration (FDA) has refused emergency authorization of ivermectin to treat coronavirus, stating for months that “[m]ore testing is needed.”
In contrast, on the other side of the world, India has embraced the treatment protocol specified by Dr. Kory and his colleagues and is now manufacturing this product under the brand name “Ziverdo Kit” and it only costs approximately $2.65 per person.
While the World is on a vaccine frenzy, the Indian Government is distributing a home Covid Kit with Zinc, Doxycycline and Ivermectin. The cost $2.65 per person. pic.twitter.com/CphhwO8pXE
— Sam Bardo (@SamBardo1) December 16, 2020
Though the U.S. National Institutes of Health (NIH) recommends no treatment for those suffering from SARS-COV-2 “unless the patient is hospitalized and requires oxygen,” in India, they began treating coronavirus patients early, including the use of hydroxychloroquine (HCQ).
Dr. Makarand Paranjpe and his wife, both 77 year-old Indian physicians, fully recovered from the COVID-19 virus using early treatment last November, TrialSiteNews (TSN) reports. She used hydroxychloroquine, and he took ivermectin.
“Without any treatment, we know that the virus enters the cells and replicates there,” Paranjpe said. “They can create disease that gets much more severe.” Stopping such replication as early as possible is the simple function of these inexpensive and safe treatments.
Last March, as debates raged in the U.S. over the merits of HCQ, following President Trump’s endorsement of the drug, India had already recommended it in its national guidelines affirming it “should be used as early in the disease course as possible…and should be avoided in patients with severe disease.”
Following the June discovery of ivermectin’s efficacy in treating the virus, along with significant subsequent testing, the largest state in their nation, Uttar Pradesh (UP) (pop. 230 million), announced in August that it was replacing their HCQ protocol with ivermectin for the prevention and treatment of COVID-19.